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ABSTRACT 
 
Although transplantation of stem cells improves recovery of the nervous tissue, little is known 
about the influence of different brain regions on transplanted cells. After we confirmed that cells 
with uniform differentiation potential can be generated in independent experiments, one million 
of neural stem cells isolated from B6.Cg-Tg(Thy1-YFP)16Jrs/J mouse embryos were 
transplanted into the brain 24 hours after induction of stroke. The lateral ventricles, the corpus 
callosum and the striatum were tested. Two and four weeks after the transplantation, the cells 
transplanted in all three regions have been attracted to the ischemic core. The largest number of 
attracted cells has been observed after transplantation into the striatum. Their differentiation 
pattern and expression of neuroligin 1, SynCAM 1, postsynaptic density protein 95 and synapsin 
1 followed the same pattern observed during in vitro cultivation and it did not differ among the 
tested regions. Differentiation pattern of the cells transplanted in the stroke-affected and healthy 
animals was the same. On the other hand, neural stem cells transplanted in the striatum of the 
animals affected by stroke exhibited significantly increased survival rates reaching 260±19%, 
when compared to cells transplanted in their wild type controls. Surprisingly, improved survival 
two and four weeks after transplantation was not due to increased proliferation of the grafted cells 
and it was accompanied by decreased levels of activity of Casp3 (19.56±3.1% in the stroke-
affected vs. 30.14±2.4% in healthy animals after four weeks). We assume that the decreased 
levels of Casp3 in cells transplanted near the ischemic region was linked to increased 
vasculogenesis, synaptogenesis, astrocytosis and axonogenesis detected in the host tissue affected 
by ischemia.  
Keywords: MCAO stroke model, stem cell transplantation, Thy1 YFP-16 mouse, synapse   
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1. Introduction 
 
Acute ischemic brain stroke is the second most common cause of death and far the most 
significant cause of permanent life-long disability [1]. With costs of care larger than one billion 
euros per year, ischemic stroke represents the most devastating medical problem of the 
humankind. The only existing treatment is fibrinolysis which has a very narrow therapeutic 
window of only few hours [2]. 
In the last two decades, a rather large number of both preclinical and clinical studies revealed that 
transplantation of stem cells promotes histological and functional recovery of the brain, including 
neurodegenerative and neurovascular diseases [3,4]. Tested cell types included embryonic stem 
cells, neural stem cells, mesenchymal stem cells and induced pluripotent stem cells [5]. 
Mechanisms of the observed beneficial effects of the transplanted cells include modulation of 
neuroinflammation, trophic effects and buffering of extracellular matrix. Several publications, 
including our own studies, have analyzed to which extent transplanted cells survived in the tissue 
affected by neuroinflammation. It has been shown that 50-70% of the cells die within one month 
after transplantation, which is linked to activation of caspase 3 and 6 [4,6,7]. 
 
Surprisingly, very few data exists on influence of the various host locations on the stem cell 
transplants, especially in regard to their survival and differentiation. Similarly, although the 
synapse represents one of the major features of neurons with a critical role in cell survival, very 
few data exist on influence of the host tissue on process of formation of synapse among 
transplanted cells. 
To elucidate behavior of stem cells after transplantation into various anatomical locations in the 
brain affected by stroke and to test how stroke affects cell survival, synaptogenesis and 
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differentiation, NSCs were transplanted into the lateral ventricles, corpus callosum and striatum 
of the mouse model of stroke. This study has shown that different brain regions influence 
transplanted NSCs, and this influence is differently displayed in stroke-affected animals and in 
their wild type controls. Surprisingly, stroke supports survival of NSCs in striatum by reducing 
activation of Casp3, but it has no influence on differentiation rate and development of synaptic 
contacts. 
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2. Material and methods 
 
2.1. Animals and housing 
B6.Cg-Tg(Thy1-YFP)16Jrs/J(Thy1 YFP-16) mouse strain (The JacksonLaboratory, Bar 
Harbor, ME, USA) was used for experimental purposes. The animals were kept on an standard 
12/12 hr light/dark cycle in a temperature controlled room (22 ± 2ºC, with 55% ± 10% humidity) 
at the animal facility at the Croatian Institute for Brain Research and were genotyped using the 
method published by our group [8]. Pelleted food and water were given ad libitum except during 
testing. All experiments on animals were approved by the Internal Review Board of the Ethical 
Committee of the School of Medicine University of Zagreb (04-77/2010-238) and Faculty of 
Veterinary Medicine (251/61-01/139-13-4), and were conducted in accordance with the EU 
Directive 2010/63/EU on the protection of animals used forscientific purposes. The minimum 
number of laboratory animals nedeed was calcultated by power analysis which justifed the 
sample size used. 
 
2.2. Isolation and cultivation of neural stem cells 
NSCs were isolated from telencephalic wall of 14.5 days old embryos originating from 
Thy1-YFP mouse strain. Isolated stem cells were cultivated in a proliferation supporting medium 
comprising of DMEM/F-12 (Gibco by Life Technologies, ThermoFisher Scientific, Pittsburgh, 
PA), B-27 Supplement (Gibco by Life Technologies), N-2 Supplement (Gibco by Life 
Technologies), Penicillin/Streptomycin (Gibco by Life Technologies), Recombinant Mouse 
Fibroblast Growth Factor-basic (FGFb, ThermoFisher Scientific, Pittsburgh, PA, USA) and 
Recombinant Mouse Epidermal Growth Factor (EGF, ThermoFisher Scientific). Cells were 
cultivated in suspension, and after two days neurospheres were formed. For the purpose of 
differentiation analyses neurospheres were dissociated, single cells and small neurospheres were 
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plated on 12-mm coverslips (200 to 250 000 cells/coverslip) as well as on 6-well plates (1 000 
000 cells/well). Coverslips and wells were previously coated with Poly-D-lysine (500 µg/mL, 
24h at 37ºC, Sigma) and laminin (10 µg/mL, 24h at 37ºC, Sigma). 24 hours after plating, the 
medium was changed into the Neurobasal (Gibco by Life Technologies) which supports neurons 
in vitro and antibiotic with glutamine (Pen Strep Glutamine, Gibco by Life Technologies). Cells 
were differentiated in followed time points: 0, 1, 3, 5 and 7 days after plating. 
 
2.3. Labelling of NSCs 
Single NSCs were labelled with two exogenous dyes according to manufacturer 
instruction: some cells were labelled with PKH26 fluorescent dye (PKH26 Red Fluorescent Cell 
Linker Kit for general cell membrane labelling, Sigma), while the other cells were incubated with 
10 µM 5-Bromo-20-deoxyuridine (BrdU, Z99% (HPLC), Sigma) solution for eight hours. 
 
2.4.  Middle cerebral artery occlusion (MCAO) 
Ischaemic brain injury was induced by transient left MCAO in three months old wild type 
mice which weighting 25-30 g. Operation was performed in inhalation anaesthesia, mixture of 
2% isoflurane in 100% O2. Surgery was performed under dissection microscope (Stemi DV4 
Spot, Zeiss). During surgery, animal body temperature was maintained with heating pad. 
Following ventral neck surgery and blood vessels preparation, intraluminal filament (Doccol 
Company, Sharon, MA, USA) was inserted through common carotid artery (CCA) into the 
internal carotid artery (ICA) to the origin middle cerebral artery (MCA) and left for 90 minutes. 
A complete block of blood flow was confirmed by Doppler sonde. After 90 minutes intraluminal 
filament was withdrawn, perfusion was restored and animal subcutaneously received analgetic 
buprenorphine (0.03 mg/kg). 
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2.5. Magnet resonance imaging 
High resolution in vivo MRI was performed on anaesthetized mice after MCAO by using 
7.0T BioSpec 70/20 USR MRI system (Bruker BioSpin, Ettlingen, Germany) equipped with an 
660 mT/m MRI RF gradient coils and 2-channel receive-only surface radiofrequency (RF) array 
coils (Bruker BioSpin, Germany) for mouse brain. Adult mice were anaesthetized with 4% 
isoflurane in a 70/30 nitrogen/oxygen gas mixture in the animal induction chamber. During MRI 
imaging, the anaesthesia was maintained with approximately 1.5% of isoflurane, and core body 
temperature and breathing rates were monitored by custom-made MobileLab Table (Medres, 
Germany) that contains complete setup for anaesthesia for small animals and includes 
temperature control unit and control system for measurment of physiological parameters 
(PhysioBox). T2 weighted (T2W) images of stroke were aquired using a TurboRARE sequence. 
T2 mapping for T2 relaxation time calculation was done according to MSME sequence protocol 
(MSME_T2map, Bruker, Germany). Afterwards, an MRI imaging was performed in a following 
form: Diffusion Weighted Image Spin-Echo (DWI-SE) and Diffusion-Tensor imaging (EPI-DTI) 
using Echo-Planar imaging. 
 
2.6. Stereotaxic injection of NSCs into the mouse brain transplantation (coordinates) 
Previously labelled NSCs were re-suspended and injected in the final concentration of one 
million cells in 1 µL DMEM medium. For stereotaxic transplantation we used two groups of 
mice: healthy and stroke affected. Stereotaxic coordinates were determined according to 
stereotaxic atlas [9]. NSCs were injected into the three brain regions: lateral ventricle (AP -0.5, 
ML +2 and DV -2.5), corpus callosum (AP -1.3, ML +2.0 and DV -1.5) and striatum (AP -0.5, 
ML +2.5 and DV -2.5). Injections were performed using small animal stereotaxic apparatus 
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(900LS, David Kopf Instruments, Tujunga, CA, USA) and Hamilton syringe needle 1µL. Avertin 
(Sigma) was used for anaesthesia at a dose of 0.5 g/kg and was given intraperitoneally. Following 
transplantation, animals were kept on the heating pad and were afterwards returned to their cages. 
 
2.7. Western blot 
Western blot analysis was performed according to standard procedures. Protein 
concentration was measured using Bradford assay (Bio-Rad Laboratories, Hercules, CA, USA). 
Protein samples were separated on 10% SDS-PAGE gel and transferred to PVDF (polyvinyl 
difluoride) membrane (Sigma-Aldrich). The membranes were blocked with 2% non-fat milk in 
PBS containing 0.05% Tween-20 (Sigma-Aldrich) for 45 min at room temperature and then 
incubated with primary antibodies at +4°C overnight. Primary and secondary antibodies used for 
western blot analysis were listed in Table 1.)  
Table 1. Primary and secondary antibodies used for Western blot analysis.  
Primary antibodies 
Antibody Host Dilution Producer 
Actin mouse 1:15000 Millipore (MAB1501) 
Neuroligin 1 rabbit 1:1750 Millipore (AB15512) 
PSD-95 rabbit 1:1500 Cell Sigaling (mAb #3409) 
SynCAM 1 rabbit 1:2500 Millipore (ABT66) 
Synapsin 1 rabbit 1:1500 Cell Signaling (#2312) 
Secondary antibodies 
Antibody Dilution Producer 
goat anti-mouse IgG H&L (HRP) 1:15000 Abcam (ab6789) 
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goat anti-rabbit IgG H&L (HRP)  1:3000 Abcam (ab6721) 
 
2.8. Immunohistochemistry and immunocytochemistry 
This method have been described previously [10] with modification of adding 10 mM 
sodium citrate which was used as antigen retrival for cells and tissues labelled with BrdU [11]. 
Primary and secondary antibodies used for immunohisto- and immunocytochemistry are listed in 
Table 2.)  
Table 2. Primary and secondary antibodies used for immunohist- and 
immunocytochemistry.  
Primary antibodies 
Antibody Host Dilution Producer 
BrdU mouse 1:750 Cell Signaling (mAb #5292) 
Cleaved Caspase-3 rabbit 1:400 Call Signaling (#9661)  
GAP43 rabbit 1:500 Novus Biologicals (NB300-143) 
GFAP chicken 1:250 Abcam (ab4674) 
Ki67 rabbit 1:300 Abcam (ab15580) 
Laminin rabbit 1:100 Sigma (L9393) 
MAP2 chicken 1:1000 Abcam (ab5392) 
Nestin mouse 1:200 Millipore (MAB353) 
Neuroligin 1 rabbit 1:200 Millipore (AB15512) 
Neuroligin 1 mouse 1:400 Synaptic Systems (129 111) 
PSD95 rabbit 1:250 Cell Sigaling (mAb #3409) 
SMI-32 rabbit 1:500 Merck (NE1023) 
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SynCAM 1 rabbit 1:250 Millipore (ABT66) 
Synapsin 1 rabbit 1:100 Cell Signaling (#2312) 
Secondary antibodies 
Antibody Dilution Producer 
Alexa Fluor 488 goat anti-chicken IgG 1:1000 Invitrogen (A11039) 
Alexa Fluor 488 goat anti-mouse IgG 1:1000 Invitrogen (A11001) 
Alexa Fluor 488 goat anti-rabbit IgG 1:1000 Invitrogen (A11034) 
Alexa Fluor 546 goat anti-chicken IgG 1:1000 Invitrogen (A11040) 
Alexa Fluor 546 goat anti-mouse IgG 1:1000 Invitrogen (A11003) 
Alexa Fluor 546 goat anti-rabbit IgG 1:1000 Invitrogen (A11010) 
 
2.9. Cell counting 
Number of positive cells was counted on photographs obtained by confocal microscope 
(LSM 510 Meta, Zeiss). Measurements were obtained using inbuild Zeiss software combined by 
macro adding from ImageJ. When graft regions were analyzed, average region size was 0.8 mm2 
(0.6 – 1.2 mm2). Number of cells counted depended on the tested groups and it was in the range 
of 800143 to 3200465 cells. For quantification of cells in vitro, days 0, 1, 3, 5 and 7 were 
analysed. Statistical analysis was performed by ANOVA with Bonferroni post hoc test 
(significance difference: *p< 0.05, **p<0.01, ***p<0.001). The pooled mean of marker positive 
cells and pooled SD (Welch–Satterthwaite equation) was obtained by combining the results (n=5) 
of three independent experiments. The results were rated independently by two evaluators and 
coincided 100%. 
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2.10. Statistical analysis 
Data are reported as mean ± standard error of mean (error bars) of three independent 
experimental measurments, each performed in triplicate, for immunocytochemistry. An overall 
difference in samples data were analyzed by two-way analysis of variance (ANOVA) followed 
by Student T-test for pairwise comparison and Bonferroni post hoc test for multiple comparisons 
in order to test for significance between individual measurments and/or groups of surface 
markers. Significance level was set at p= 0.05 (significant differences between groups are marked 
by * for p< 0.05, ** for p< 0.01, *** for p< 0001). 
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3. Results 
 
3.1. Standardized procedure of cell isolation and cultivation before transplantation yielded 
uniform cell populations 
 
To test if our protocol yields reproducible and standardized neural stem cell population, 
their proliferation and differentiation potential was measured in three consecutive experiments. 
NSCs isolated from E14.5 fetal telencephalon proliferated in vitro as neurospheres in the 
presence of growth factors EGF and FGF. Their proliferation was followed by measuring the 
number of Ki67+-cells. After removal of growth factors from the culture, the number of nestin+-
cells decreased within seven days from 99.3±0.80% to 22.77±22.61%, while the number of 
MAP2+-neurons in the same period reached 73.4±13.53%. Since GFAP+-astrocytes require 
longer incubation, they were recognized as 4.8±4.23% of the cells in the total population around 
the seventh day of cultivation (Fig. 1A). The procedure has been performed in three independent 
experiments. No significant effects in the total variability of differentiation have been observed 
(Fig. 1B). This revealed that our protocol yields cell populations which can be reliably compared 
in different experiments. 
 
3.2. Expression of synaptic proteins gradually increased during in vitro and in vivo 
differentiation of NSCs 
 
The expression of genes and the presence of synaptic proteins were observed in this study, 
using them as markers of early networking. Intercellular contacts were measured by expression of 
PSD-95, Nlgn1, SynCAM 1 and Syn1. The expression of synaptic proteins and their detection in 
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cells were gradually increasing during seven days of NSCs differentiation, as shown by RT-PCR, 
Western blot and immunohistochemistry of all four synaptic proteins. Expression and presence of 
Nlgn1, SynCAM 1 and Syn1 increased on average five times in seven days of differentiation, 
while PSD-95 in the same period increased three times (Fig. 2). 
 
Immunocytochemical analysis revealed a specific expression pattern for each marker. Nlgn1, 
SynCAM 1 and PSD-95 exhibited a strong perinuclear signal in the cytoplasm of undifferentiated 
nestin+-cells. From the third day in in vitro conditions, all markers showed an intense punctate 
staining in differentiating MAP2+-neurons. This probably represents preformed protein 
aggregates required for synapse formation. Nlgn1, SynCAM 1 and PSD-95 exhibited different 
expression pattern in dendrites. Nlgn1 exhibited the strongest signal expressed diffusely in the 
dendritic cytoplasm (not shown), while SynCAM 1 exhibited the weakest signal limited only to 
the initial part (Fig. 3). PSD-95 was mostly present in dendrites. Syn1, as a presynaptic protein, 
marking presence of more mature synapse had a specific and different expression pattern from 
other analyzed synaptic proteins. It exhibited a faint signal in nestin+- cells, but also a punctate 
staining (present exclusively in growing axons) from the third day of a culture. With further cell 
growth and differentiation, Syn1+- puncta could often be found adjacent to the postsynaptic 
somatic and dendritic membrane. After transplantation into the brain, the presence of the same 
synaptic proteins was found in transplanted cells (Fig. 3). This was in congruency with reports 
published by our group that expression pattern of different genes in vitro with great 
reproducibility mirrors expression of genes in vivo [10]. Interestingly, we did not observe any 
differences in expression of synaptogenic proteins in transplanted cells between the stroke 
affected and healthy control animals (not shown). 
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3.3. Behavior of transplanted neural stem cells depended on the host brain region 
 
To test how different regions of the brain influence migration, survival and differentiation 
of grafted NSCs, the cells, marked by PKH26 and BrdU were transplanted into three different 
niches: the lateral ventricles, corpus callosum and the striatum. Neural stem cells transplanted 
into the corpus callosum migrated along the border of white and grey matter (Fig. 4A). In the 
healthy animals NSCs migrated a rather short distance not more than 1200 micrometers in both 
directions, while in the stroke-affected animals 85% of NSCs migrated 2500 micrometers 
towards the ischemic injury and populated the region of ischemia. In the same time, 15% of the 
cells have migrated toward the contralateral hemisphere (Fig. 4A). After reaching the ischemic 
region, NSCs have accumulated in both penumbra and the core of the stroke.  
NSCs transplanted in the lateral ventricles of both healthy and stroke-affected animals 
survived in the cerebrospinal (CS) fluid for four weeks, which was the end point of our 
experiment. In that region, the cells were forming neurospheres like during their in vitro 
cultivation (Fig. 4B). Approximately 25% of NSCs started with spontaneous differentiation into 
MAP2+/NeuN+/Tuj1+-neurons in the lateral ventricles, while majority of the cells remained in the 
nestin-positive multipotent state. In the healthy animals, NSCs remained exclusively in the 
ventricles, while in the stroke-affected animals 15% of cells migrated outside of the CS fluid into 
the surrounding brain parenchyma. This migration was noticeable on the stroke- affected side and 
the distance, measured from lateral ventricle, was on average not larger than 400 micrometers 
(Fig. 4B). In the following weeks, NSCs have differentiated into MAP2+/NeuN+/Tuj1+-neurons. 
Number of cells, which have populated ischemia - affected region after transplantation in the 
lateral ventricle was 5 times lower when compared to animals in which cells have been 
transplanted in corpus callosum. 
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Neural stem cells transplanted in the striatum of healthy animals remained in the place of 
transplantation and undergo differentiation. In the stroke affected animals, a massive migration 
involving more than 75% of cells towards the ischemic region was observed. Since 
transplantation in this case was near the place of ischemia, migration was a rather short distance, 
on average 400 micrometers. The majority of cells accumulated in the region of penumbra or in 
the core of the ischemic lesion (fig. 4C). 
 
3.4. Stroke improved the survival rates of transplanted neural stem cells in the striatum while 
it had no significant influence on their differentiation or on any of tested parameters of cells 
transplanted in other regions of brain 
 
In this work we have shown that MCAO method combined with Doppler sensor leads to 
obtaining uniform brain ischemia - stroke affecting mostly the motor cortex and striatum of the 
experimental animal (Supplementary Fig. 1). In this study no statistically significant differences 
in survival and differentiation of transplanted NSCs between stroke affected and control animals 
into the lateral ventricle or corpus callosum were not observed. On the other hand, transplantation 
into the striatum revealed significant differences: four weeks after transplantation we have found 
260±19% more transplanted cells in the striatum affected by stroke than in the control animals. In 
order to check if the observed difference was related to hypothesized increased cell proliferation 
in the brain affected by ischemia, the number of Ki67+-cells was counted. However, in both 
stroke affected and healthy animals, number of cells expressing Ki67 was 1.5±0.7%. This 
suggested that proliferation might not be the reason for higher number of cells. Moreover, we 
measured presence of activated caspase 3 (Casp3). In the graft present in striatum of the brain 
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affected by ischemia, number of Casp3+-cells after two weeks and even after four weeks 
(18.43±2.6% and 19.56±3.1%, respectively) was significantly lower when compared to healthy 
control after two weeks and after four weeks (28.59±5.1% and 30.14±2.4%, respectively) (Fig. 
5). Therefore, it was suggested that larger size of the graft in the brain affected by ischemia after 
2 and 4 weeks might be due to decreased apoptosis and not to increased cell proliferation.  
Transplanted NSCs have differentiated into Thy1+/MAP2+/NeuN+-neurons and GFAP+-astrocytes 
in the injured brain as well as in the control. Again, there were no observed differences in 
differentiation of cells in the stroke-affected and healthy animals. The expression of synaptic 
proteins was detected in transplanted NSCs, however predominantly in differentiating neurons. 
Thy1+-neurons were positive for Nlgn1, PSD-95 and SynCAM 1. SynCAM 1 showed a strong 
perinuclear signal, while PSD-95 and Nlgn1 had a stronger signal in the cytoplasm of the 
neurites. The expression of tested synaptic proteins in differentiated NSCs was present in cells 
transplanted in the injured as well as control tissue. Also the proportion of NSCs differentiating 
into either neurons or astrocytes did not differ between these two groups (Fig. 5).  
 
3.5. Brain tissue affected by ischemia exhibited high level of remodeling, including increased 
expression of synaptic markers 
 
Since we have observed that NSCs transplanted in the striatum survived better in the brain 
affected by stroke than in its healthy control, we searched for possible reasons that could be 
detected in the host tissue. Immunohistochemical expression of antibodies against laminin, GAP 
43 and GFAP revealed intensive remodeling of the injured brain tissue which started two days 
after the initial insult and had lasted for more than four weeks (Fig. 6). Laminin signal was 
detected two days after ischemia and was getting stronger, thus suggesting increased 
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angiogenesis especially in the penumbra, but also visible in the ischemic core. GAP 43+-growing 
axons surrounded the ischemic core and bridged it on the periphery. GFAP+-astrocytes showed 
an intensive reactive gliosis in the recovering brain. All observed processes (angiogenesis, 
activation of astrocytes and axonogenesis) could have contributed to increased graft survival 
discovered in the brain affected by ischemia.  
Since our results showed that transplanted cells do undergo syanaptogenesis, it was also 
checked whether an increased synaptogenesis can be detected in the host tissue. Indeed, as 
opposed to the healthy brain, brain affected by ischemia exhibited a strong upregulation of all the 
synaptic proteins analyzed (Nlgn1, SynCAM 1, PSD-95, Syn1). Nlgn1+-cells coming from the 
host were detected in migration towards the injured site. Moreover, Nlgn1+-cells have been found 
in both ipsilateral and contralateral hippocampus of the brain affected by stroke (not shown). 
PSD-95+-progenitors were much more exclusive and were discovered only in the small layer 
facing the ischemic core. All synaptic proteins were also strongly expressed in the outgrowing 
neurites in the penumbra (Fig. 6). 
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4. Discussion 
 
In this work we showed that standardization of protocol leads to obtaining a uniform population 
of NSCs with well-defined properties. In vitro testing of independent batches of cell samples 
revealed progressive differentiation towards neurons and glia in ratios which do not differ 
significantly in different experiments. This was an important finding because reproducible 
parameters of NSCs differentiation and survival are a prerequisite for analyzing behavior of these 
cells after transplantation in the brain of experimental animals. Our recent findings showed that 
the birth and differentiation of neurons after transplantation of NSCs in the host brain tissue 
follow the same pattern like the one observed in in vitro system and during embryonic 
development [10]. Taken altogether, the cell behavior, observed after transplantation in the brain, 
is mostly, if not exclusively, caused by features of the host tissue and not by differences among 
various stem cell samples. 
 
Results obtained in the last two decades suggested that transplanted neural stem cells survive for 
some period in the host tissue where they contribute to repair of damaged tissue [4,12]. This is 
achieved by at least three mechanisms: generation of new neurons [13,14], production of healing 
molecules [15] and promotion of endogenous neurogenesis [16]. This study has confirmed our 
previous findings that upon transplantation NSCs give rise to both neurons and glia. Although it 
is unclear to which extent it is required that transplanted stem cells survive and differentiate into 
region-specific cells, it is reasonable to measure the success of transplantation procedures based 
on survival of the transplanted cells. In this study, it was clearly shown that different regions of 
the brain influence differently behavior of transplanted NSCs. Therefore, NSCs transplanted in 
the lateral ventricles form neurospheres in the cerebrospinal fluid, which is similar to their in 
19 
 
vitro behavior. We have been able to find some cells migrating towards ischemic region, but the 
number of migrating cells was very small. Majority of formed neurospheres remained attached to 
the ependyme and some of transplanted cells integrated into the ependymal epithelium. 
Interestingly, we have not observed major differences between stroke-affected mice and their 
healthy controls. Similar finding was reported by [17], who transplanted NSCs in the lateral 
ventricles of the healthy rat. Cells mostly remained attached to the wall and only some of them 
migrated towards the cortex. Park et al. [18] reported similar findings in healthy dogs, but they 
have also found cells in hippocampus and even in the spinal cord. It is possible that this 
difference is due to the relatively larger number of transplanted cells which leads to larger 
number of cells that migrate toward other regions of the brain. Similar publication reported 
events after transplantation of umbilical stem cells in the patient with global ischemia. 
Transplanted cells did not leave lateral ventricles even after 33 months of their monitoring [19]. 
This corresponds to our finding in the mouse with a massive stroke where cells mostly remain in 
the ventricles. Experiments in which cells have been transplanted in the lateral ventricles in the 
animal models of demyelination offered contradictory results: while [20] reported that human 
glial precursors cells do not leave injection point, [21] reported massive migration out of 
ventricles. 
 
Transplantation of NSCs into the corpus callosum of the stroke affected brain results in their 
migration towards the injured region. This is in a congruency with reports which describe how 
cells migrate using white matter tracts [22]. This work has shown that the cells migrate toward 
the ischemic area and in lower extent towards the uninjured contralateral hemisphere. It would be 
interesting to perform post-transplantation analyses of these cells and check if there are some 
differences in expression of surface markers which could be linked to migration in the specific 
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direction. It is possible that some cells do not detect signals present in the tissue affected by 
stroke, so their migration in ipsilateral or contralateral direction is occurring with the same 
probability. One could discuss why cells which are not attracted by ischemia do migrate at all. 
The reason for that might be that cells search for a differentiation niche. On the other hand, 
transplantation in the striatum leads to their survival in a large number at the place of 
transplantation. Afterwards, they migrate towards penumbra and in ischemic core and, after 
reaching their target, majority of them undergo differentiation [4,6,23]. Recently, de la Rosa-
Prieto and colleagues reported that brain ischemia significantly influenced migration and axonal 
projections of human skin derived iPSCs. Transplanted cells migrated toward ischemic lesion and 
no difference in survival, proliferation or differentiation between cells transplanted in stroke 
affected and healthy tissue have been observed [24]. 
 
One of the most important results of this study was observation that transplanted NSCs survive in 
larger number in the niche affected by inflammation than in its wild type control. By counting 
number of Ki67+ and Casp3+-cells, it was suggested that larger number of cells found in stroke-
affected brain compared to its control was due to decreased apoptosis of NSCs and not to their 
increased proliferation. To reliably follow transplanted cells, they have been marked by PKH26 
and BrdU, which allow precise tracing of cells up to 6 weeks after transplantation. Multiplication 
of cells slowly dilutes the signal, but for the needed period of 4 weeks, its presence was still 
clearly visible. Interestingly, stroke-affected brain did not influence differentiation of NSCs, so 
the observed ratio of neurons and glia was the same in the stroke affected brains and in their wild 
type controls. The same was observed when comparing ratio of presence of synaptogenic 
markers, which suggests that stroke influences survival of cells, but not their differentiation 
pattern. Although it has been shown that the core of ischemia or a late stage neuroinflammatory 
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disease is hostile for cell transplants, there are evidences from both preclinical and clinical trials 
suggesting that stem cells are much more attracted to disease-affected nervous tissue than to its 
healthy control. Equally, if cells find their niche, they survive longer in regions affected by 
reversible inflammation than in completely healthy tissue. In this work we suggest that at least 
one part of this improved survival is linked to decreased apoptosis. Recently, new data have 
started to reveal new roles of Casp3. While its activity is primarily linked to programmed cell 
death, changes in its levels are also linked to re-organization of the brain tissue. Our group has 
reported that immediately after stroke, a high expression and presence of activated Casp3 can be 
detected and this is linked to colocalization with GAP 43 [25]. This process is linked not only to 
cell removal after stroke, but also to reorganization at the synapse level. It has been reported that 
Casp3 is involved in differentiation of cells [26, 27] and elimination of synapses, thus its 
downregulation might be the mechanism involved in adaptation on ischemia needed for cell 
survival. Indeed, there is a growing list of evidences that decreased activity of Casp3 is an 
important mechanism involved in protection against ischemia [28,29]. Further analyses will be 
needed to understand molecular pathways behind observed increase of expression of Casp3 in the 
brain affected by ischemia and decreased expression of Casp3 in the transplanted neural stem 
cells. 
 
Our in vitro experiments revealed that NSCs express markers of synaptogenesis and their pattern 
of expression increases gradually over time, following their differentiation. Here we showed that 
Nlgn1 is already expressed after 24 hours of cell cultivation. Acting as a postsynaptic cell 
adhesion protein which interact with neurexin, neuroligin is a potent inducer of formation of 
synapse. Its early presence during NSCs differentiation in in vitro conditions thus suggest that 
synaptogenesis might be occuring symultaneously with their transformation into neurons. 
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Interstingly, our results showed that Nlgn1 is expressed very early on GFAP+-cells. This might 
be the earliest sign of the synaptic triad. Our study has detected PSD-95 during differntiation of 
NSCs, thus confirming the well known fact that PSD-95 comes in the contact with Nlgn1, which 
is one of the key events for synapse formation [30,31,32]. While Nlgn1 is required for the 
formation of excitatory synapses [33] (Kwon et al., 2012), it seems that coordinated activity of 
Nlgn1 and PSD-95 leads to the formation of dendritic spines [33,34]. Our finding is similar to the 
one reported by [35] who have recognized PSD-95 as one of the major markers of early 
synaptogenic activity of transplanted NSCs. 
 
Importantly, there was no difference in the expression of synaptogenic proteins in transplanted 
NSCs between stroke-affected brain and its healthy control. This suggests that expression of 
synaptogenic proteins is process occurring independently of the host niche. Since we have shown 
that NSCs survive better in an ischemic niche, we have tested several markers of tissue 
reorganization which might promote cell survival. We found increased expression of laminin, 
GFAP and GAP 43. Increased expression of laminin is a natural reaction of the brain linked to 
increased neuronal regeneration. The role of laminin in mobilization of neuroblasts and formation 
of new neurons has been showed in in vitro experiments [36]. Increased expression of GAP 43 is 
possibly linked to at least two processes: GAP 43 has a central role in sprouting of new axons 
after injury, but also regulates the organization of presynaptic terminal and neurotransmitter 
release. The role of GAP 43 and its link to Casp3 has been discussed in details in the publication 
of our group [25] (Gorup et al., 2015). 
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 Figure legends 
 
Fig. 1. Neural stem cells differentiation in vitro. 
(A) Expression of nestin, MAP2 and GFAP in neural stem cells culture during seven days 
analyzed by immunocytochemistry. (B) Comparison of measurements of expression of markers 
in three independent experiments/counting. B(1) Expression of progenitor marker nestin was the 
highest in nondiferentiated NSCs (99.3±0.80%), but decreased significantly during the next seven 
days of differentiation (22.77±22.61%). B(2) expression of neuronal marker MAP2 increased 
significantly from 1.67±3,55% to 73.4±13.53% in a time-dependent manner. B(3) Increase in 
number of GFAP+-astrocytes was detected on the seventh day of neuronal differentiation with the 
value of 4.8±4.23%. Number of positive cells for each marker (nestin, MAP2 and GFAP) was 
expressed as mean (%) ± SD of one quintuplicate experiment that was representative of three 
independent experiments. Statistical analysis revealed no significant differences in three 
independent experiments. 
 
Fig. 2. Analysis of presence of synaptic markers in the culture of neural stem cells during 
differentation at days 1, 3, 5 and 7 measured by Western blot. 
Statistically significant increase in the expression of all four synaptic markers, normalized to -
actin, was visible on the seventh day of differentiation when compared to the first day: (A) Syn 1, 
(B) Nlgn1, (C) PSD-95 and (D) SynCAM 1.  
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Fig. 3. Presence of SynCAM 1 in MAP2+ neurons (in vitro) and Thy1+ neurons (in vivo). 
Double immunohistochemical visualization of SynCAM 1 (green) and either MAP2 (B and C) in 
in vitro or Thy1 (E and F) in in vivo. (A-C). SynCAM 1 expression detected in the cytoplasm of 
MAP2+-neurons after 5 days of in vitro cultivation. (D-F) SynCAM 1 expression in transplanted 
Thy1 neural stem cells, detected after 4 weeks in the host brain tissue. Scale bars = 100 m. 
 
Figure 4. Behaviour of NSC transplanted into the mouse brain. 
Behaviour of PKH26 (red) labelled and transplanted NSC into the mouse brain affected by stroke 
and its healthy control. (A) Migration of transplanted NSC along the corpus callosum. 85% of the 
cells migrate towards the stroke and they travel on average 2500 µm. In the healthy control, they 
migrate equally in both directions and the average distance is 1200 µm. (B) 15% of the cells 
transplanted in the lateral ventricle of the stroke-affected animal migrate out of it and travel on 
average 400 µm towards the stroke. In the healthy animal cells remain in the ventricle. (C) 75% 
of the cells transplanted in the striatum of the stroke-affected animal migrate towards the 
ischemic region and the average distance is 400 µm. In the healthy animal cells remain in the 
region of injection. Scale bar 100 µm. 
 
Fig. 5. Analyses of the fate of transplanted Thy1+ neural stem cells into the stroke-affected 
brain and in its healthy control. 
Comparison of the grafts in the brain affected by ischemia (A) reveals larger graft size after 4 
weeks than in its wild type control (B). Quantification and comparison of graft sizes 4 weeks 
after transplantation (C): The survival of transplanted NSCs was more than two times higher in 
the injured tissue than in its healthy control (n=4, *p <0.05). Ratios of newly formed neurons (D) 
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and astrocytes (F) compared to total number of cells in grafts in both stroke-affected and healthy 
control brains were the same. (n=4, *p <0.05). (E) Percentage of Casp3 – positive cells 2 and 4 
weeks after transplantation in the stroke-affected and healthy brain. Improved survival of 
transplanted NSCs observed in the stroke-affected brain was due to decreased cell death. The 
values of Casp3+-positive cells are represented as the mean (%)±SD (n=3). Scale bar = 100 m  
 
Fig. 6. Immunohistochemical presentation of reactive changes in postischemic brain tissue. 
(A) Reactive gliosis at the border with ischemia-affected region detected by GFAP+, (B) reactive 
angiogenesis in the penumbra marked by laminin+-blood vessels and (C) ingrowth of GAP 43+-
axons from penumbra towards the iscehmic core. Scale bars = (A) 50 m, (B and C) 100 m.  
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